[EN] DIAZABICYCLONONENE AND TETRAHYDROPYRIDINE DERIVATIVES AS RENIN INHIBITORS<br/>[FR] DERIVES DE DIAZABICYCLONONENE ET DE TETRAHYDROPYRIDINE UTILISES COMME INHIBITEURS DE LA RENINE
申请人:ACTELION PHARMACEUTICALS LTD
公开号:WO2005040173A1
公开(公告)日:2005-05-06
The invention relates to novel bicyclic derivatives and related compounds and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as inhibitors of renin.
9-Azabicyclo'3.3.1 inon-6-ee derivatives with a heteroatom at the 3-position as renin inhibitors
申请人:Bezencon Olivier
公开号:US20060258648A1
公开(公告)日:2006-11-16
The invention relates to novel 9-azabicyclo[3.3.1]nonene derivatives and related compounds and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as inhibitors of renin.
Novel diazabicyclononene and tetrahydropyridine derivatives with a new polar side-chain
申请人:Bezencon Olivier
公开号:US20070135405A1
公开(公告)日:2007-06-14
The invention relates to novel bicyclic derivatives and related compounds and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as inhibitors of renin.
Bridged N-Bicyclic Sulfonamido Inhibitors of Gamma Secretase
申请人:Konradi Andrei W.
公开号:US20110178119A1
公开(公告)日:2011-07-21
The invention provides N-bicyclic sulfonamido compounds of Formula (I) wherein A is as described in the specification and R
1
and R
2
combine to form a [3.3.1] or a [3.2.1] ring system. Compounds of Formula I are useful in treating or preventing cognitive disorders, such as Alzheimer's Disease. The invention also encompasses pharmaceutical compositions comprising compounds of Formula (I) as well as methods of treating cognitive disorders, such as Alzheimer's disease.